PT - JOURNAL ARTICLE AU - Elizabeth C. Dubovsky AU - Tim N. Booth AU - Gilbert Vezina AU - Carole A. Samango-Sprouse AU - Kathryn M. Palmer AU - Cynthia O. Brasseux TI - MR Imaging of the Corpus Callosum in Pediatric Patients with Neurofibromatosis Type 1 DP - 2001 Jan 01 TA - American Journal of Neuroradiology PG - 190--195 VI - 22 IP - 1 4099 - http://www.ajnr.org/content/22/1/190.short 4100 - http://www.ajnr.org/content/22/1/190.full SO - Am. J. Neuroradiol.2001 Jan 01; 22 AB - BACKGROUND AND PURPOSE: Many pediatric patients with neurofibromatosis type 1 (NF-1) have an apparent increased thickness of the corpus callosum (CC) on sagittal T1-weighted images compared with patients not affected by NF-1. In this study, we compared the surface area of the CC in children with NF-1 with that of healthy pediatric control subjects to determine if this was another common intracranial manifestation of NF-1.METHODS: Midsagittal T1-weighted MR images of 43 consecutive children with NF-1 and 43 age- and gender-matched healthy control subjects were reviewed retrospectively. The surface area of the CC and the midsagittal intracranial skull surface (MISS) area were measured five times each on all midsagittal images. A mean CC to mean midline intracranial surface area ratio (CC/MISS) was calculated for each.RESULTS: There is a statistically significant increase in the mean CC surface area in pediatric patients with NF-1 (680 mm2 ±98, range 509–974 mm2) compared with control subjects (573 mm2 ± 83, range 404–797 mm2). The mean MISS is significantly increased in patients with NF-1 (16568 mm2 ± 1161, range 14107–19394 mm2 vs 15402 mm2 ± 1133, range 12951–17905 mm2 for control subjects). CC/MISS was also significantly increased in the patients with NF-1 relative to the control subjects (.0410 ± .0043, range .0330–.0530 vs .0372 ± .0043, range .0270–.0470 for control subjects).CONCLUSION: A larger midsagittal surface area of the CC is another intracranial manifestation of NF-1 that can be demonstrated by sagittal MR imaging. The etiology is unclear, but could be related to abnormal neurofibromin and Ras protein activity. Potential clinical relevance is discussed herein.